Key result
Oral nifedipine administration in hospitalized patients was characterized by inappropriate prescribing, with 63% of orders given over the telephone and 98% lacking bedside evaluation.
Why the study?
What are the prescribing habits and clinical outcomes associated with oral nifedipine capsule use for hypertension in hospitalized patients?
Observational (n=83)
Yes
What are the prescribing habits and clinical outcomes associated with oral nifedipine capsule use for hypertension in hospitalized patients?
Oral nifedipine is frequently prescribed inappropriately for asymptomatic blood pressure elevations in hospitalized patients without adequate bedside evaluation, leading to potentially severe adverse events.
Inappropriate nifedipine prescribing without evaluation may persist; leaves open links to adverse events in observational data.
Despite the absence of an approved Food and Drug Administration (FDA) indication, the use of oral or "sublingual" nifedipine for hypertension in the hospitalized patient has become an increasingly common practice. The purpose of the study was to assess the clinical circumstances for which the drug was being prescribed and the practices of attending and resident physicians. Dosing of oral nifedipine capsules in medical and surgical inpatients was studied prospectively in three central Connecticut hospitals (University, community-teaching, and private nonteaching) during a 60-day period from January to March, 1994. Through evaluation of computerized pharmacy and medical records, data were collected on diagnostic reasons for ordering nifedipine, pre- and posttreatment blood pressures, dosing frequency, clinical documentation associated with drug prescription, and adverse events. Physicians and nurses at the respective hospitals were unaware of the conduct of the study. The incidence of nifedipine capsule administration at all three hospitals was 3.4% (152 dosings in 83 patients/4489 hospitalized patients/ 60 days). Practice habits and blood pressure changes differed minimally among hospitals and physicians. Sixty-three percent of nifedipine orders were given over the telephone for arbitrary and asymptomatic blood pressure elevations and 98% of the orders lacked bedside patient evaluation. Follow-up of the blood pressure was performed within 1 h in 51% of patients and within 2 h in 24%, while in 25% there was no documentation of follow-up until 2 to 6 h after nifedipine dosing. Mean pretreatment blood pressure was 186/94 +/- 20/16 mm Hg (range: 150 to 260 mm Hg systolic and 50 to 125 mm Hg diastolic). Blood pressure fell 32/16 +/- 22/16 mm Hg (range: -92 to +8 mm Hg systolic and -90 to +28 mm Hg diastolic) and was related to the level of pretreatment blood pressure (r = 0.53 for systolic blood pressure, and r = 0.49 for diastolic blood pressure, P < .001 for both). Large, asymptomatic blood pressure reductions were common. One hypertensive patient experienced severe hypotension accompanied by an anterior wall myocardial infarction. These data demonstrate inappropriate physician prescribing of oral nifedipine in hospitalized patients characterized by a lack of proper assessment prior to drug dosing, highly arbitrary treatment parameters that were written without regard for symptoms or underlying illnesses, and slow follow-up for evaluation of the clinical response to therapy.
No takes yet. Share an insight, caveat, or question.
Rehman et al. (1996) conducted an observational in Hypertension in hospitalized patients (n=83). Oral nifedipine capsules was evaluated on Clinical circumstances, physician practices, and blood pressure changes. Oral nifedipine administration in hospitalized patients was characterized by inappropriate prescribing, with 63% of orders given over the telephone and 98% lacking bedside evaluation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: